World delirium awareness and quality survey in 2023—a worldwide point prevalence study

dc.contributor
Institut Català de la Salut
dc.contributor
[Lindroth H] Department of Nursing, Division of Nursing Research, Mayo Clinic, Rochester, MN, USA. Center for Aging Research, Regenstrief Institute, Center for Health Innovation and Implementation Science, School of Medicine, Indiana University, Indianapolis, IN, USA. [Liu K] Critical Care Research Group, The Prince Charles Hospital, Brisbane, Australia. Institute for Molecular Bioscience (IMB), The University of Queensland, Brisbane, Queensland, Australia. Non-Profit Organization ICU Collaboration Network (ICON), Tokyo, Japan. [Szalacha L] Department of Nursing, Division of Nursing Research, Mayo Clinic, Rochester, MN, USA. Family Medicine and Spor ts Medicine, University of South Florida, Morsani College of Medicine, USF Health, Tampa, FL, USA. Family Medicine and Spor ts Medicine, University of South Florida, Morsani College of Medicine, USF Health, Tampa, FL, USA. [Ashkenazy S] General ICU, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. [Bellelli G] School of Medicine and Surgery, Milano-Bicocca University, Milan, Italy. Acute Geriatric Unit, IRCCS San Gerardo Foundation, Monza, Italy. [van den Boogaard M] Depar tment Intensive Care, Radboud University Medica Center, Nijmegen, the Netherlands. [Morandi A] Intermediate Care and Rehabilitation, Azienda Speciale Cremona Solidale, Cremona, Italy. Parc Sanitari Per Virgili, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Lindroth, Heidi
dc.contributor.author
Liu, Keibun
dc.contributor.author
Szalacha, Laura
dc.contributor.author
Ashkenazy, Shelly
dc.contributor.author
van den Boogaard, RN, PhD, Mark
dc.contributor.author
Bellelli, Giuseppe
dc.contributor.author
Morandi, Alessandro
dc.date.accessioned
2025-10-24T08:48:43Z
dc.date.available
2025-10-24T08:48:43Z
dc.date.issued
2025-03-07T12:06:02Z
dc.date.issued
2025-03-07T12:06:02Z
dc.date.issued
2024-11
dc.identifier
Lindroth H, Liu K, Szalacha L, Ashkenazy S, Bellelli G, van den Boogaard M, et al. World delirium awareness and quality survey in 2023—a worldwide point prevalence study. Age Ageing. 2024 Nov;53(11):afae248.
dc.identifier
1468-2834
dc.identifier
http://hdl.handle.net/11351/12720
dc.identifier
10.1093/ageing/afae248
dc.identifier
39568389
dc.identifier
001361095300001
dc.identifier.uri
http://hdl.handle.net/11351/12720
dc.description.abstract
Delivery of health care; Global delirium prevalence; Older people
dc.description.abstract
Prestación de servicios de salud; Prevalencia mundial del delirio; Personas mayores
dc.description.abstract
Prestació d'atenció sanitària; Prevalença mundial del deliri; Gent gran
dc.description.abstract
Background: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia. Objectives: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities. Design: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023. Participants: Clinicians or researchers with access to clinical data. Main outcome and measure: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed. Results: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%). Conclusion and relevance: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
dc.format
application/pdf
dc.language
eng
dc.publisher
Oxford University Press
dc.relation
Age and Ageing;53(11)
dc.relation
https://doi.org/10.1093/ageing/afae248
dc.rights
Attribution-NonCommercial 4.0 International
dc.rights
http://creativecommons.org/licenses/by-nc/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Scientia
dc.subject
Persones grans
dc.subject
Enquestes
dc.subject
Salut mundial
dc.subject
Deliri - Diagnòstic
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence
dc.subject
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires
dc.subject
DISEASES::Nervous System Diseases::Neurologic Manifestations::Neurobehavioral Manifestations::Confusion::Delirium
dc.subject
PUBLIC HEALTH::Health Care (Public Health)::Health of Specific Groups::Global Health
dc.subject
NAMED GROUPS::Persons::Age Groups::Adult::Aged
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::morbilidad::prevalencia
dc.subject
TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios
dc.subject
ENFERMEDADES::enfermedades del sistema nervioso::manifestaciones neurológicas::manifestaciones neuroconductuales::confusión::delirio confusional
dc.subject
SALUD PÚBLICA::atención a la salud (salud pública)::salud de grupos específicos::salud global
dc.subject
DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::adulto::anciano
dc.title
World delirium awareness and quality survey in 2023—a worldwide point prevalence study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)